Clinical Trial Update: Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describing the use of low-dose decitabine with a modified BUCY conditioning regimen for high-risk acute myeloid leukemia patients undergoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Dacogen (decitabine) (decitabine)
• Total Body Irradiation

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2, Phase 3 | Status: UNKNOWN